CPIX logo

CPIX Cash From Financing

Annual CFF

-$7.42 M
-$5.36 M-260.10%

December 31, 2023


Summary


Performance

CPIX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCPIXcash flowmetrics:

Quarterly CFF

-$536.80 K
-$227.20 K-73.39%

September 30, 2024


Summary


Performance

CPIX Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCPIXcash flowmetrics:

TTM CFF

$88.20 K
+$345.80 K+134.24%

September 30, 2024


Summary


Performance

CPIX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCPIXcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

CPIX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-260.1%+63.9%+101.2%
3 y3 years-4.3%-240.2%+101.7%
5 y5 years-204.0%+64.8%+101.7%

CPIX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-260.1%at low-113.7%+83.6%-96.3%+100.9%
5 y5-year-260.1%at low-113.7%+83.6%-96.3%+100.9%
alltimeall time-111.0%+40.1%-100.8%+91.1%-99.9%+100.7%

Cumberland Pharmaceuticals Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$536.80 K(+73.4%)
$88.20 K(-134.2%)
Jun 2024
-
-$309.60 K(-112.8%)
-$257.60 K(-92.0%)
Mar 2024
-
$2.42 M(-262.8%)
-$3.22 M(-56.6%)
Dec 2023
-$7.42 M(+260.1%)
-$1.49 M(+68.5%)
-$7.42 M(-14.8%)
Sep 2023
-
-$882.60 K(-73.1%)
-$8.72 M(-11.3%)
Jun 2023
-
-$3.28 M(+84.1%)
-$9.83 M(+26.6%)
Mar 2023
-
-$1.78 M(-36.0%)
-$7.76 M(+276.3%)
Dec 2022
-$2.06 M(-42.0%)
-$2.78 M(+39.7%)
-$2.06 M(>+9900.0%)
Sep 2022
-
-$1.99 M(+64.8%)
-$16.30 K(-100.7%)
Jun 2022
-
-$1.21 M(-130.8%)
$2.36 M(+41.8%)
Mar 2022
-
$3.92 M(-632.9%)
$1.66 M(-146.8%)
Dec 2021
-$3.55 M(-50.1%)
-$735.30 K(-292.0%)
-$3.55 M(-32.3%)
Sep 2021
-
$383.00 K(-120.1%)
-$5.25 M(-19.8%)
Jun 2021
-
-$1.90 M(+46.6%)
-$6.55 M(-5.3%)
Mar 2021
-
-$1.30 M(-46.6%)
-$6.91 M(-2.9%)
Dec 2020
-$7.12 M(+40.1%)
-$2.43 M(+165.5%)
-$7.12 M(+14.6%)
Sep 2020
-
-$915.50 K(-59.6%)
-$6.21 M(-10.6%)
Jun 2020
-
-$2.27 M(+50.8%)
-$6.95 M(+29.5%)
Mar 2020
-
-$1.50 M(-1.5%)
-$5.36 M(+5.6%)
Dec 2019
-$5.08 M(-171.2%)
-$1.53 M(-7.5%)
-$5.08 M(-233.2%)
Sep 2019
-
-$1.65 M(+140.8%)
$3.81 M(-24.2%)
Jun 2019
-
-$685.00 K(-43.9%)
$5.03 M(+5.2%)
Mar 2019
-
-$1.22 M(-116.6%)
$4.78 M(-33.0%)
Dec 2018
$7.14 M(+266.5%)
$7.37 M(-1806.4%)
$7.14 M(+903.5%)
Sep 2018
-
-$431.80 K(-53.8%)
$711.30 K(-46.9%)
Jun 2018
-
-$935.00 K(-182.3%)
$1.34 M(-63.1%)
Mar 2018
-
$1.14 M(+20.7%)
$3.63 M(+86.4%)
Dec 2017
$1.95 M(-269.8%)
$941.50 K(+378.4%)
$1.95 M(+201.6%)
Sep 2017
-
$196.80 K(-85.5%)
$645.70 K(+67.1%)
Jun 2017
-
$1.36 M(-348.3%)
$386.30 K(-235.2%)
Mar 2017
-
-$545.90 K(+51.4%)
-$285.80 K(-75.1%)
Dec 2016
-$1.15 M(-77.9%)
-$360.50 K(+475.9%)
-$1.15 M(-39.1%)
Sep 2016
-
-$62.60 K(-109.2%)
-$1.88 M(-36.7%)
Jun 2016
-
$683.20 K(-148.5%)
-$2.98 M(-39.5%)
Mar 2016
-
-$1.41 M(+28.2%)
-$4.92 M(-5.3%)
Dec 2015
-$5.19 M
-$1.10 M(-5.1%)
-$5.19 M(+1.9%)
Sep 2015
-
-$1.16 M(-8.1%)
-$5.10 M(+7.7%)
Jun 2015
-
-$1.26 M(-25.1%)
-$4.73 M(+81.2%)
DateAnnualQuarterlyTTM
Mar 2015
-
-$1.68 M(+68.0%)
-$2.61 M(+57.1%)
Dec 2014
-$1.66 M(-81.8%)
-$1.00 M(+26.2%)
-$1.66 M(-71.6%)
Sep 2014
-
-$792.90 K(-191.9%)
-$5.84 M(-20.3%)
Jun 2014
-
$862.70 K(-217.9%)
-$7.33 M(-12.5%)
Mar 2014
-
-$731.60 K(-85.9%)
-$8.38 M(-8.5%)
Dec 2013
-$9.15 M(+117.6%)
-$5.18 M(+127.0%)
-$9.15 M(+153.6%)
Sep 2013
-
-$2.28 M(+1147.7%)
-$3.61 M(+11.6%)
Jun 2013
-
-$183.00 K(-87.8%)
-$3.23 M(-25.7%)
Mar 2013
-
-$1.51 M(-515.5%)
-$4.35 M(+3.5%)
Dec 2012
-$4.21 M(+17.6%)
$362.30 K(-119.0%)
-$4.21 M(-30.1%)
Sep 2012
-
-$1.91 M(+46.6%)
-$6.02 M(+11.6%)
Jun 2012
-
-$1.30 M(-4.3%)
-$5.40 M(+32.4%)
Mar 2012
-
-$1.36 M(-6.2%)
-$4.07 M(+13.8%)
Dec 2011
-$3.58 M(-71.1%)
-$1.45 M(+13.0%)
-$3.58 M(+382.6%)
Sep 2011
-
-$1.28 M(-6684.1%)
-$741.60 K(-86.5%)
Jun 2011
-
$19.50 K(-102.3%)
-$5.48 M(-30.2%)
Mar 2011
-
-$864.60 K(-162.3%)
-$7.85 M(-36.7%)
Dec 2010
-$12.39 M(-118.4%)
$1.39 M(-123.1%)
-$12.39 M(-2.1%)
Sep 2010
-
-$6.02 M(+156.1%)
-$12.65 M(-121.1%)
Jun 2010
-
-$2.35 M(-56.5%)
$59.87 M(-3.1%)
Mar 2010
-
-$5.40 M(-582.1%)
$61.77 M(-8.1%)
Dec 2009
$67.18 M(-1380.1%)
$1.12 M(-98.3%)
$67.18 M(+4.0%)
Sep 2009
-
$66.51 M(<-9900.0%)
$64.58 M(-2801.0%)
Jun 2009
-
-$456.40 K(-4757.1%)
-$2.39 M(-47.0%)
Mar 2009
-
$9800.00(-100.7%)
-$4.51 M(-14.0%)
Dec 2008
-$5.25 M(+34.4%)
-$1.48 M(+219.7%)
-$5.25 M(+11.3%)
Sep 2008
-
-$463.30 K(-82.0%)
-$4.72 M(-21.3%)
Jun 2008
-
-$2.58 M(+255.1%)
-$5.99 M(+46.5%)
Mar 2008
-
-$725.90 K(-23.5%)
-$4.09 M(+4.8%)
Dec 2007
-$3.90 M(-176.4%)
-$948.90 K(-45.5%)
-$3.90 M(+16.5%)
Sep 2007
-
-$1.74 M(+158.0%)
-$3.35 M(+62.1%)
Jun 2007
-
-$675.00 K(+25.3%)
-$2.07 M(-145.8%)
Mar 2007
-
-$538.70 K(+36.4%)
$4.51 M(-11.7%)
Dec 2006
$5.11 M(+74.8%)
-$395.00 K(-13.8%)
$5.11 M(-7.2%)
Sep 2006
-
-$458.30 K(-107.8%)
$5.50 M(-7.7%)
Jun 2006
-
$5.90 M(+9837.7%)
$5.96 M(>+9900.0%)
Mar 2006
-
$59.40 K
$59.40 K
Dec 2005
$2.92 M
-
-

FAQ

  • What is Cumberland Pharmaceuticals annual cash flow from financing activities?
  • What is the all time high annual CFF for Cumberland Pharmaceuticals?
  • What is Cumberland Pharmaceuticals annual CFF year-on-year change?
  • What is Cumberland Pharmaceuticals quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Cumberland Pharmaceuticals?
  • What is Cumberland Pharmaceuticals quarterly CFF year-on-year change?
  • What is Cumberland Pharmaceuticals TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Cumberland Pharmaceuticals?
  • What is Cumberland Pharmaceuticals TTM CFF year-on-year change?

What is Cumberland Pharmaceuticals annual cash flow from financing activities?

The current annual CFF of CPIX is -$7.42 M

What is the all time high annual CFF for Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals all-time high annual cash flow from financing activities is $67.18 M

What is Cumberland Pharmaceuticals annual CFF year-on-year change?

Over the past year, CPIX annual cash flow from financing activities has changed by -$5.36 M (-260.10%)

What is Cumberland Pharmaceuticals quarterly cash flow from financing activities?

The current quarterly CFF of CPIX is -$536.80 K

What is the all time high quarterly CFF for Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals all-time high quarterly cash flow from financing activities is $66.51 M

What is Cumberland Pharmaceuticals quarterly CFF year-on-year change?

Over the past year, CPIX quarterly cash flow from financing activities has changed by +$950.30 K (+63.90%)

What is Cumberland Pharmaceuticals TTM cash flow from financing activities?

The current TTM CFF of CPIX is $88.20 K

What is the all time high TTM CFF for Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals all-time high TTM cash flow from financing activities is $67.18 M

What is Cumberland Pharmaceuticals TTM CFF year-on-year change?

Over the past year, CPIX TTM cash flow from financing activities has changed by +$7.51 M (+101.19%)